Addex Therapeutics Ltd (ADXN) Financials
ADXN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 6.7 million | 2.4 million |
| 2023-06-30 | 10.0 million | 3.2 million |
| 2023-03-31 | 8.0 million | 3.5 million |
| 2022-12-31 | 9.0 million | 3.6 million |
ADXN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.5 million | 528056 |
| 2023-06-30 | -3.1 million | 545720 |
| 2023-03-31 | -2.6 million | 471761 |
| 2022-12-31 | -3.3 million | 740631 |
ADXN Net Income
No data available :(
ADXN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 5.2 million | - | 353138 |
| 2023-06-30 | 8.0 million | - | 258642 |
| 2023-03-31 | 6.1 million | - | 283495 |
| 2022-12-31 | 7.5 million | - | 403576 |
ADXN Shares Outstanding
ADXN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 740 | 910351 | 1.9 million | - |
| 2023-06-30 | 2769 | 836332 | 2.2 million | - |
| 2023-03-31 | 2701 | 775462 | 2.0 million | - |
| 2022-12-31 | 1 | 6.2 million | 260311 | - |
ADXN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 357961 | - |
| 2023-06-30 | 701756 | 2.1 million |
| 2023-03-31 | 548014 | 1.9 million |
| 2022-12-31 | 640762 | 15.8 million |
ADXN
Price: $16.10
52 week price:
Earnings Per Share: -20.01 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 497200
Market Capitalization: 19.8 million